We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Higher Efficacy of Blood Gas and Electrolyte Analyzers Driving Adoption in ICUs and Emergency Care

By LabMedica International staff writers
Posted on 31 Aug 2022
Print article
Image: The global blood gas and electrolyte analyzers is expected to reach USD 6.5 billion by 2032 (Photo courtesy of Pexels)
Image: The global blood gas and electrolyte analyzers is expected to reach USD 6.5 billion by 2032 (Photo courtesy of Pexels)

Blood gas and electrolyte analyzers are extensively used for the patients with conditions such as diabetes, hemorrhage, drug overdose, and others. These analyzers detect the blood levels, oxygen concentration, and several parameters for early diagnosis. The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 5.6% between 2022 to 2030, to reach USD 6.5 billion by 2030, driven by the increasing use of blood gas and electrolyte analyzers in intensive care units (ICUs) and emergency departments. Additionally, the growing adoption of electronic health records (EHR) and development of advanced blood gas analyzers with laboratory information systems, along with higher investment in healthcare services by governments across the world is also expected to drive market growth.

These are the latest findings of Fact.MR (Dublin, Ireland), a market research and consulting agency.

Integration of advanced technology in healthcare devices has been a boon to patients as well as the healthcare industry. The availability of portable blood analyzers coupled with the introduction of automated analyzers have led to increased demand in the market. Portable and fully automated blood and gas electrolyte analyzers require only anticoagulated blood sample and can measure multiple parameters. Hence, healthcare professionals are using these to improve the handling process and accuracy of blood tests. As a result, the demand for blood and gas electrolyte analyzers is predicted to surge by 1.5x over the forecast period.

Going forwards, the efficacy of blood gas and electrolytes in treating patients in critical and emergency situations is likely to drive demand. Consistent quality control and accuracy in error detection will continue to make blood gas and electrolyte analyzers the preferred choice for healthcare providers. Moreover, lack of alternative devices and techniques for measuring oxygen concentration and other parameters for chronic illnesses will also drive sales. However, the high cost of blood analyzers and electrolytes is likely to slow down their adoption rate, especially in the developing countries. In addition, the availability of refurbished devices and slow/non-approval of blood analyzers from FDA could hamper market growth.

By product type, the blood gas analyzers segment is expected to lead the market, owing to its growing use in disease detection. Based on modality, portable blood gas and electrolyte analyzers are anticipated to remain the preferred choice in the healthcare industry owing to their ease of use and affordability. In terms of end user, diagnostic centers and clinical laboratories are expected to witness a steady growth over the projection period. Geographically, North America is expected to be the world’s largest market for blood gas and electrolyte analyzers, with the U.S. leading the demand, while South Asia is expected to be the most lucrative market for blood gas and electrolyte analyzers, with India spearheading the region’s growth through 2022 and beyond.

 

 

Gold Supplier
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
New
Automated Immunoassay Analyzer
cobas e 411
New
Whole Blood Control
ESR-Chex Plus
New
5-Diff Auto Hematology Analyzer
iCell-8800

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Metabolomic profiling reveals risk of multiple diseases all at once (Photo courtesy of BIH)

Single Blood Test Predicts Risk of Multiple Diseases Simultaneously Using AI

Prevention is better than cure. To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible.... Read more

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The MC-80 digital cell morphology analyzer can screen and diagnose malignant and non-malignant blood diseases (Photo courtesy of Mindray)

Mindray Showcases Hematology Innovations at ISLH 2022

Mindray (Shenzhen, China) showcased its hematology innovations and academic achievements to medical experts from Europe and around the world at the International Symposium on Technological Innovations... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.